Why sleep might matter for vaccine protection
Vaccines work by prompting the immune system to produce antibodies, and sleep is thought to support the immune system's ability to form those responses. A systematic review of eight studies—five on influenza, two on hepatitis A, and one on hepatitis B—found that six out of eight reported a positive correlation between sufficient sleep and higher antibody levels after vaccination [1]. This suggests that sleep around the time of vaccination could be a simple way to boost vaccine effectiveness, but the review does not separate sleep before vaccination from sleep after vaccination.
The review also looked at the time of day of vaccination as a separate factor. Out of seven studies on timing, four reported that morning vaccination led to better antibody production than afternoon vaccination, including one study on an inactivated SARS-CoV-2 vaccine [1]. However, this is about the clock time of the shot, not whether sleep happens before or after. The review's conclusion that morning vaccination and sufficient sleep could enhance immune response is a general proposal, not a finding that sleep timing relative to the shot is the key.
What COVID-19 vaccine studies show about sleep and timing
For COVID-19 vaccines specifically, the picture is less clear. A study of 428 adults who received mRNA vaccines (Pfizer or Moderna) found that poorer overall sleep quality was associated with lower neutralizing antibody levels six months after vaccination, independent of age, sex, BMI, smoking, and vaccine type [4]. When researchers looked at sleep duration measured by a wearable device, shorter sleep was linked to lower six-month antibody levels only among those who received the Pfizer vaccine, and this was a trend-level finding [4]. The same study found no evidence that the time of day of vaccination was associated with antibody levels at one or six months [4].
Another study of 1,090 participants in Spain (639 without prior COVID-19 infection) examined night shift work and sleep duration. It found no overall association between night shift work and vaccine-induced antibody responses, though night workers tended to have lower IgG levels—a difference that was not statistically significant [3]. However, participants who reported sleeping six hours or less had significantly lower IgM antibody levels compared to those who slept seven hours [3]. This study did not compare sleep before versus after vaccination; it looked at habitual sleep patterns around the time of vaccination.
Does the vaccine type change the sleep effect?
The evidence hints that the link between sleep and antibody levels may depend on the vaccine. The systematic review included studies on influenza, hepatitis A, and hepatitis B, and most found a positive correlation between sleep and antibody response [1]. But the review does not report whether the strength of that correlation differed by vaccine type, so it is not possible to say that one vaccine is more affected than another.
For COVID-19, the study of mRNA vaccines found that the association between shorter sleep duration and lower six-month antibodies was present only for the Pfizer vaccine, not Moderna, though this was a trend-level interaction [4]. That study did not include other vaccine types. The night-shift study included both Pfizer and AstraZeneca vaccines and adjusted for vaccine type, but it did not report whether the sleep-duration effect differed between them [3]. So while there are hints that vaccine type matters, the evidence is not strong enough to draw firm conclusions.
Before versus after vaccination: what we still don't know
None of the studies directly compared sleep on the night before vaccination with sleep on the nights after vaccination. The systematic review treats "sufficient sleep" as a general factor around the time of vaccination, without separating before from after [1]. The COVID-19 studies measured habitual sleep quality or duration over weeks to months, not sleep specifically before or after the shot [3][4]. So the question of whether sleep before versus after vaccination matters differently remains unanswered by these studies.
What the evidence does suggest is that getting enough sleep—especially avoiding short sleep of six hours or less—is associated with better antibody responses for some vaccines, and that this may be more relevant for certain vaccine types like Pfizer's mRNA vaccine [3][4]. But the timing of that sleep relative to the vaccination is not something these studies can resolve. Future research that specifically tracks sleep on the nights before and after vaccination, across different vaccine types, would be needed to answer that part of the question.
Sources used in this answer
Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A Systematic Review of the Current Evidence and a Proposal for COVID-19 Vaccination.
A systematic review of eight studies found that six reported a positive correlation between sufficient sleep and higher antibody levels after vaccination, and four of seven studies on timing found morning vaccination was better than afternoon for antibody production, including one SARS-CoV-2 vaccine study.
Previous COVID-19 Infection and Antibody Levels After Vaccination
Previously infected individuals had higher and more sustained antibody levels after COVID-19 vaccination than those without prior infection, but the study did not examine sleep timing.
O-205 Night shift work and sleep deprivation in relation to vaccine induced SARS-CoV-2 antibody responses in a general population cohort (COVICAT study)
In a general population cohort, night shift work was not overall associated with vaccine-induced antibody levels, but participants sleeping six hours or less had significantly lower IgM antibody levels than those sleeping seven hours.
0099 Impact of Sleep and Timing of Vaccination on Neutralizing Antibody Responses to the COVID-19 Vaccine
Poorer global sleep quality was associated with lower neutralizing antibody levels six months after mRNA COVID-19 vaccination, and shorter sleep duration was linked to lower antibodies only for the Pfizer vaccine at a trend level, while time of day of vaccination showed no association.
The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine
A 3-antigen hepatitis B vaccine led to higher seroprotection rates and antibody titers than a single-antigen vaccine after 2.5 years, but the study did not investigate sleep.
